āĻšā§āĻŽGBT âĸ EPA
add
Guerbet SA
ā§¨ā§¨.ā§Ģā§ĻâŦ
ā§Ē āĻā§āĻ˛, ā§Ŧ:ā§Ļā§Ļ:ā§Ļā§Ļ PM GMT +ā§¨ · EUR · EPA · āĻĄāĻŋāĻ¸āĻā§āĻ˛ā§āĻŽāĻžāĻ°
āĻāĻžāĻ˛ āĻļā§āĻˇ āĻ¯ā§ āĻĻāĻžāĻŽā§ āĻāĻŋāĻ˛
ā§¨ā§¨.ā§Šā§ĢâŦ
āĻ¸āĻžāĻ°āĻž āĻĻāĻŋāĻ¨ā§āĻ° āĻā§āĻ°ā§āĻĄāĻŋāĻā§ā§ āĻ¸ā§āĻāĻā§āĻ° āĻĻāĻžāĻŽā§āĻ° āĻāĻ āĻž āĻ¨āĻžāĻŽāĻžāĻ° āĻ°ā§āĻā§āĻ
ā§¨ā§§.ā§Ŧā§ĢâŦ - ā§¨ā§¨.ā§ā§ĻâŦ
āĻ¸āĻžāĻ°āĻž āĻŦāĻāĻ°ā§āĻ° āĻ°ā§āĻā§āĻ
ā§§ā§.ā§Ēā§¨âŦ - ā§Ēā§Ļ.ā§¨ā§ĢâŦ
āĻŽāĻžāĻ°ā§āĻā§āĻ āĻā§āĻ¯āĻžāĻĒ
ā§¨ā§Ž.ā§Ģā§§Â āĻā§ EUR
āĻāĻĄāĻŧ āĻāĻ˛āĻŋāĻāĻŽ
ā§§ā§Ž.ā§Ļā§ŽÂ āĻšāĻž
P/E āĻ
āĻ¨ā§āĻĒāĻžāĻ¤
ā§¨ā§§.ā§§ā§¨
āĻ˛āĻā§āĻ¯āĻžāĻāĻļ āĻĒā§āĻ°āĻĻāĻžāĻ¨
-
āĻĒā§āĻ°āĻžāĻāĻŽāĻžāĻ°āĻŋ āĻāĻā§āĻ¸āĻā§āĻā§āĻ
EPA
āĻŦāĻžāĻāĻžāĻ° āĻ¸āĻāĻŦāĻžāĻĻ
The Motley Fool
ā§Ŧ āĻāĻ¨ā§āĻāĻž āĻāĻā§
Here's the Smartest Way to Invest in the S&P 500 in July
ā§Ļ.ā§Žā§Š%
āĻĢāĻžāĻāĻ¨āĻžāĻ¨ā§āĻ¸āĻŋā§āĻžāĻ˛ āĻĒāĻžāĻ°āĻĢāĻ°ā§āĻŽā§āĻ¯āĻžāĻ¨ā§āĻ¸
āĻā§ā§āĻ° āĻ¸ā§āĻā§āĻāĻŽā§āĻ¨ā§āĻ
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ
| (EUR) | āĻĄāĻŋāĻ¸ā§ ā§¨ā§Ļā§¨ā§Ēinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | ā§¨ā§§.ā§Šā§§Â āĻā§ | ā§¨.ā§Ēā§Ž% |
āĻŦā§āĻ¯āĻŦāĻ¸āĻž āĻāĻžāĻ˛āĻžāĻ¨ā§āĻ° āĻāĻ°āĻ | ā§§ā§Š.ā§¯ā§Â āĻā§ | ā§Ŧ.ā§Žā§Š% |
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | ā§¨ā§Ģ.ā§Ģā§¨Â āĻ˛āĻž | -ā§ā§Ŧ.ā§Ģā§% |
āĻ¨ā§āĻ āĻĒā§āĻ°āĻĢāĻŋāĻ āĻŽāĻžāĻ°ā§āĻāĻŋāĻ¨ | ā§§.ā§¨ā§Ļ | -ā§ā§.ā§§ā§Ļ% |
āĻļā§ā§āĻžāĻ° āĻĒā§āĻ°āĻ¤āĻŋ āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | â | â |
EBITDA | ā§§.ā§¯ā§¨Â āĻā§ | -ā§¨ā§¨.ā§Ŧā§Ļ% |
āĻĒā§āĻ°āĻ¯ā§āĻā§āĻ¯ āĻā§āĻ¯āĻžāĻā§āĻ¸ā§āĻ° āĻšāĻžāĻ° | ā§¨ā§Ģ.ā§Ļā§% | â |
āĻŦā§āĻ¯āĻžāĻ˛ā§āĻ¨ā§āĻ¸ āĻļāĻŋāĻ
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
| (EUR) | āĻĄāĻŋāĻ¸ā§ ā§¨ā§Ļā§¨ā§Ēinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻā§āĻ¯āĻžāĻļ āĻ āĻāĻŽ āĻ¸āĻŽā§ā§āĻ° āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ | ā§Ģ.ā§Ļā§¨Â āĻā§ | -ā§¨.ā§Ļā§Š% |
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ | ā§§ā§Ļā§Š.ā§ā§ŠÂ āĻā§ | ā§§.ā§§ā§% |
āĻŽā§āĻ āĻĻāĻžā§ | ā§Ŧā§Ē.ā§Ģā§Â āĻā§ | -ā§Ļ.ā§¨ā§Ļ% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§Šā§¯.ā§§ā§Ŧ āĻā§ | â |
āĻāĻāĻāĻ¸ā§āĻā§āĻ¯āĻžāĻ¨ā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāĻ° | ā§§.ā§¨ā§Ŧ āĻā§ | â |
āĻĒā§āĻ°āĻžāĻāĻ¸ āĻā§ āĻŦā§āĻ āĻ°ā§āĻļāĻŋāĻ | ā§Ļ.ā§ā§§ | â |
āĻ¸āĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | ā§¨.ā§¨ā§Š% | â |
āĻŽā§āĻ˛āĻ§āĻ¨ āĻĨā§āĻā§ āĻā§ | ā§¨.ā§¯ā§Ē% | â |
āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨
| (EUR) | āĻĄāĻŋāĻ¸ā§ ā§¨ā§Ļā§¨ā§Ēinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | ā§¨ā§Ģ.ā§Ģā§¨Â āĻ˛āĻž | -ā§ā§Ŧ.ā§Ģā§% |
āĻ
āĻĒāĻžāĻ°ā§āĻļāĻ¨ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āĻ¯āĻžāĻļ | ā§Š.ā§Ģā§Ģ āĻā§ | ā§§ā§.ā§¯ā§§% |
āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | -ā§§.ā§Ēā§Â āĻā§ | ā§§ā§Š.ā§ā§% |
āĻĢāĻžāĻāĻ¨ā§āĻ¯āĻžāĻ¨ā§āĻ¸āĻŋāĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | -ā§§.ā§Ēā§ŽÂ āĻā§ | -ā§§ā§Ģā§Ļ.ā§Ģā§Ŧ% |
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ | ā§Ģā§Ŧ.ā§Ģā§ŽÂ āĻ˛āĻž | -ā§§ā§Ļ.ā§Ļā§Ļ% |
āĻĢā§āĻ°āĻŋ āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§ | ā§¨ā§Ļ.ā§Ēā§ŽÂ āĻ˛āĻž | -ā§ā§Ē.ā§§ā§Ģ% |
āĻ¸āĻŽā§āĻĒāĻ°ā§āĻā§
Guerbet is a France-based manufacturer of contrast agents used in medical imaging. The company was founded in 1926 by AndrÊ Guerbet, the son of Marcel Guerbet who in 1901 discovered Lipiodol â the first iodinated X-ray contrast agent.
In 2017 Guerbetâs revenues were âŦ807.1 million. It employs over 2,700 people worldwide and has manufacturing facilities in France, Ireland, Canada, Macedonia, the United States and Brazil. The companyâs headquarters, formerly located in Villepinte, is currently located in Chicago, and its shares are included in the NASDAQ stock index.
In July 2015, Guerbet announced the takeover of a portion of Mallinckrodt's contrast media and application systems divisions. The acquisition was completed in November 2015. Wikipedia
āĻ¸āĻŋāĻāĻ
āĻ¸ā§āĻĨāĻžāĻĒāĻŋāĻ¤ āĻšā§ā§āĻā§
ā§§ā§¯ā§¨ā§Ŧ
āĻā§ā§āĻŦāĻ¸āĻžāĻāĻ
āĻāĻ°ā§āĻŽāĻāĻžāĻ°ā§
ā§¨,ā§Žā§Ēā§¨
